Sustainability of Blood Pressure Reduction in Black Barbershops

BACKGROUND:We developed a new model of hypertension care for non-Hispanic black men that links health promotion by barbers to medication management by American Society of Hypertension–certified pharmacists and demonstrated efficacy in a 6-month cluster-randomized trial. The marked reduction in systo...

Full description

Saved in:
Bibliographic Details
Published inCirculation (New York, N.Y.) Vol. 139; no. 1; pp. 10 - 19
Main Authors Victor, Ronald G, Blyler, Ciantel A, Li, Ning, Lynch, Kathleen, Moy, Norma B, Rashid, Mohamad, Chang, L Cindy, Handler, Joel, Brettler, Jeffrey, Rader, Florian, Elashoff, Robert M
Format Journal Article
LanguageEnglish
Published United States by the American College of Cardiology Foundation and the American Heart Association, Inc 02.01.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract BACKGROUND:We developed a new model of hypertension care for non-Hispanic black men that links health promotion by barbers to medication management by American Society of Hypertension–certified pharmacists and demonstrated efficacy in a 6-month cluster-randomized trial. The marked reduction in systolic blood pressure (BP) seen at 6 months warranted continuing the trial through 12 months to test sustainability, a necessary precondition for implementation research. METHODS:We enrolled a cohort of 319 black male patrons with systolic BP ≥140 mm Hg at baseline. Fifty-two Los Angeles County barbershops were assigned to either a pharmacist-led intervention or an active control group. In the intervention group, barbers promoted follow-up with pharmacists who prescribed BP medication under a collaborative practice agreement with patrons’ primary care providers. In the control group, barbers promoted follow-up with primary care providers and lifestyle modification. After BP assessment at 6 months, the intervention continued with fewer in-person pharmacist visits to test whether the intervention effect could be sustained safely for 1 year while reducing pharmacist travel time. Final BP and safety outcomes were assessed in both groups at 12 months. RESULTS:At baseline, mean systolic BP was 152.4 mm Hg in the intervention group and 154.6 mm Hg in the control group. At 12 months, mean systolic BP fell by 28.6 mm Hg (to 123.8 mm Hg) in the intervention group and by 7.2 mm Hg (to 147.4 mm Hg) in the control group. The mean reduction was 20.8 mm Hg greater in the intervention (95% CI, 13.9–27.7; P<0.0001). A BP <130/80 mm Hg was achieved by 68.0% of the intervention group versus 11.0% of the control group (P<0.02). These new 12-month efficacy data are statistically indistinguishable from our previously reported 6-month data. No treatment-related serious adverse events occurred in either group over 12 months. Cohort retention at 12 months was 90% in both groups. CONCLUSIONS:Among black male barbershop patrons with uncontrolled hypertension, health promotion by barbers resulted in large and sustained BP reduction over 12 months when coupled with medication management by American Society of Hypertension–certified pharmacists. Broad-scale implementation research is both justified and warranted. CLINICAL TRIAL REGISTRATION:URLhttps://www.clinicaltrials.gov. Unique identifierNCT 02321618.
AbstractList We developed a new model of hypertension care for non-Hispanic black men that links health promotion by barbers to medication management by American Society of Hypertension-certified pharmacists and demonstrated efficacy in a 6-month cluster-randomized trial. The marked reduction in systolic blood pressure (BP) seen at 6 months warranted continuing the trial through 12 months to test sustainability, a necessary precondition for implementation research. We enrolled a cohort of 319 black male patrons with systolic BP ≥140 mm Hg at baseline. Fifty-two Los Angeles County barbershops were assigned to either a pharmacist-led intervention or an active control group. In the intervention group, barbers promoted follow-up with pharmacists who prescribed BP medication under a collaborative practice agreement with patrons' primary care providers. In the control group, barbers promoted follow-up with primary care providers and lifestyle modification. After BP assessment at 6 months, the intervention continued with fewer in-person pharmacist visits to test whether the intervention effect could be sustained safely for 1 year while reducing pharmacist travel time. Final BP and safety outcomes were assessed in both groups at 12 months. At baseline, mean systolic BP was 152.4 mm Hg in the intervention group and 154.6 mm Hg in the control group. At 12 months, mean systolic BP fell by 28.6 mm Hg (to 123.8 mm Hg) in the intervention group and by 7.2 mm Hg (to 147.4 mm Hg) in the control group. The mean reduction was 20.8 mm Hg greater in the intervention (95% CI, 13.9-27.7; P<0.0001). A BP <130/80 mm Hg was achieved by 68.0% of the intervention group versus 11.0% of the control group ( P<0.02). These new 12-month efficacy data are statistically indistinguishable from our previously reported 6-month data. No treatment-related serious adverse events occurred in either group over 12 months. Cohort retention at 12 months was 90% in both groups. Among black male barbershop patrons with uncontrolled hypertension, health promotion by barbers resulted in large and sustained BP reduction over 12 months when coupled with medication management by American Society of Hypertension-certified pharmacists. Broad-scale implementation research is both justified and warranted. URL: https://www.clinicaltrials.gov . Unique identifier: NCT 02321618.
BACKGROUND:We developed a new model of hypertension care for non-Hispanic black men that links health promotion by barbers to medication management by American Society of Hypertension–certified pharmacists and demonstrated efficacy in a 6-month cluster-randomized trial. The marked reduction in systolic blood pressure (BP) seen at 6 months warranted continuing the trial through 12 months to test sustainability, a necessary precondition for implementation research. METHODS:We enrolled a cohort of 319 black male patrons with systolic BP ≥140 mm Hg at baseline. Fifty-two Los Angeles County barbershops were assigned to either a pharmacist-led intervention or an active control group. In the intervention group, barbers promoted follow-up with pharmacists who prescribed BP medication under a collaborative practice agreement with patrons’ primary care providers. In the control group, barbers promoted follow-up with primary care providers and lifestyle modification. After BP assessment at 6 months, the intervention continued with fewer in-person pharmacist visits to test whether the intervention effect could be sustained safely for 1 year while reducing pharmacist travel time. Final BP and safety outcomes were assessed in both groups at 12 months. RESULTS:At baseline, mean systolic BP was 152.4 mm Hg in the intervention group and 154.6 mm Hg in the control group. At 12 months, mean systolic BP fell by 28.6 mm Hg (to 123.8 mm Hg) in the intervention group and by 7.2 mm Hg (to 147.4 mm Hg) in the control group. The mean reduction was 20.8 mm Hg greater in the intervention (95% CI, 13.9–27.7; P<0.0001). A BP <130/80 mm Hg was achieved by 68.0% of the intervention group versus 11.0% of the control group (P<0.02). These new 12-month efficacy data are statistically indistinguishable from our previously reported 6-month data. No treatment-related serious adverse events occurred in either group over 12 months. Cohort retention at 12 months was 90% in both groups. CONCLUSIONS:Among black male barbershop patrons with uncontrolled hypertension, health promotion by barbers resulted in large and sustained BP reduction over 12 months when coupled with medication management by American Society of Hypertension–certified pharmacists. Broad-scale implementation research is both justified and warranted. CLINICAL TRIAL REGISTRATION:URLhttps://www.clinicaltrials.gov. Unique identifierNCT 02321618.
We developed a new model of hypertension care for non-Hispanic black men that links health promotion by barbers to medication management by American Society of Hypertension-certified pharmacists and demonstrated efficacy in a 6-month cluster-randomized trial. The marked reduction in systolic blood pressure (BP) seen at 6 months warranted continuing the trial through 12 months to test sustainability, a necessary precondition for implementation research.BACKGROUNDWe developed a new model of hypertension care for non-Hispanic black men that links health promotion by barbers to medication management by American Society of Hypertension-certified pharmacists and demonstrated efficacy in a 6-month cluster-randomized trial. The marked reduction in systolic blood pressure (BP) seen at 6 months warranted continuing the trial through 12 months to test sustainability, a necessary precondition for implementation research.We enrolled a cohort of 319 black male patrons with systolic BP ≥140 mm Hg at baseline. Fifty-two Los Angeles County barbershops were assigned to either a pharmacist-led intervention or an active control group. In the intervention group, barbers promoted follow-up with pharmacists who prescribed BP medication under a collaborative practice agreement with patrons' primary care providers. In the control group, barbers promoted follow-up with primary care providers and lifestyle modification. After BP assessment at 6 months, the intervention continued with fewer in-person pharmacist visits to test whether the intervention effect could be sustained safely for 1 year while reducing pharmacist travel time. Final BP and safety outcomes were assessed in both groups at 12 months.METHODSWe enrolled a cohort of 319 black male patrons with systolic BP ≥140 mm Hg at baseline. Fifty-two Los Angeles County barbershops were assigned to either a pharmacist-led intervention or an active control group. In the intervention group, barbers promoted follow-up with pharmacists who prescribed BP medication under a collaborative practice agreement with patrons' primary care providers. In the control group, barbers promoted follow-up with primary care providers and lifestyle modification. After BP assessment at 6 months, the intervention continued with fewer in-person pharmacist visits to test whether the intervention effect could be sustained safely for 1 year while reducing pharmacist travel time. Final BP and safety outcomes were assessed in both groups at 12 months.At baseline, mean systolic BP was 152.4 mm Hg in the intervention group and 154.6 mm Hg in the control group. At 12 months, mean systolic BP fell by 28.6 mm Hg (to 123.8 mm Hg) in the intervention group and by 7.2 mm Hg (to 147.4 mm Hg) in the control group. The mean reduction was 20.8 mm Hg greater in the intervention (95% CI, 13.9-27.7; P<0.0001). A BP <130/80 mm Hg was achieved by 68.0% of the intervention group versus 11.0% of the control group ( P<0.02). These new 12-month efficacy data are statistically indistinguishable from our previously reported 6-month data. No treatment-related serious adverse events occurred in either group over 12 months. Cohort retention at 12 months was 90% in both groups.RESULTSAt baseline, mean systolic BP was 152.4 mm Hg in the intervention group and 154.6 mm Hg in the control group. At 12 months, mean systolic BP fell by 28.6 mm Hg (to 123.8 mm Hg) in the intervention group and by 7.2 mm Hg (to 147.4 mm Hg) in the control group. The mean reduction was 20.8 mm Hg greater in the intervention (95% CI, 13.9-27.7; P<0.0001). A BP <130/80 mm Hg was achieved by 68.0% of the intervention group versus 11.0% of the control group ( P<0.02). These new 12-month efficacy data are statistically indistinguishable from our previously reported 6-month data. No treatment-related serious adverse events occurred in either group over 12 months. Cohort retention at 12 months was 90% in both groups.Among black male barbershop patrons with uncontrolled hypertension, health promotion by barbers resulted in large and sustained BP reduction over 12 months when coupled with medication management by American Society of Hypertension-certified pharmacists. Broad-scale implementation research is both justified and warranted.CONCLUSIONSAmong black male barbershop patrons with uncontrolled hypertension, health promotion by barbers resulted in large and sustained BP reduction over 12 months when coupled with medication management by American Society of Hypertension-certified pharmacists. Broad-scale implementation research is both justified and warranted.URL: https://www.clinicaltrials.gov . Unique identifier: NCT 02321618.CLINICAL TRIAL REGISTRATIONURL: https://www.clinicaltrials.gov . Unique identifier: NCT 02321618.
Author Elashoff, Robert M
Li, Ning
Blyler, Ciantel A
Lynch, Kathleen
Chang, L Cindy
Rader, Florian
Victor, Ronald G
Moy, Norma B
Rashid, Mohamad
Handler, Joel
Brettler, Jeffrey
AuthorAffiliation 1 Smidt Heart Institute at Cedars-Sinai
2 Department of Biomathematics at the David Geffen School of Medicine at UCLA
3 Department of Kaiser-Permanente
AuthorAffiliation_xml – name: 2 Department of Biomathematics at the David Geffen School of Medicine at UCLA
– name: 3 Department of Kaiser-Permanente
– name: 1 Smidt Heart Institute at Cedars-Sinai
Author_xml – sequence: 1
  givenname: Ronald
  surname: Victor
  middlename: G
  fullname: Victor, Ronald G
– sequence: 2
  givenname: Ciantel
  surname: Blyler
  middlename: A
  fullname: Blyler, Ciantel A
– sequence: 3
  givenname: Ning
  surname: Li
  fullname: Li, Ning
– sequence: 4
  givenname: Kathleen
  surname: Lynch
  fullname: Lynch, Kathleen
– sequence: 5
  givenname: Norma
  surname: Moy
  middlename: B
  fullname: Moy, Norma B
– sequence: 6
  givenname: Mohamad
  surname: Rashid
  fullname: Rashid, Mohamad
– sequence: 7
  givenname: L
  surname: Chang
  middlename: Cindy
  fullname: Chang, L Cindy
– sequence: 8
  givenname: Joel
  surname: Handler
  fullname: Handler, Joel
– sequence: 9
  givenname: Jeffrey
  surname: Brettler
  fullname: Brettler, Jeffrey
– sequence: 10
  givenname: Florian
  surname: Rader
  fullname: Rader, Florian
– sequence: 11
  givenname: Robert
  surname: Elashoff
  middlename: M
  fullname: Elashoff, Robert M
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30592662$$D View this record in MEDLINE/PubMed
BookMark eNpVUcFO3DAQtSqqstD-QpXeegkd27EdX1otqxZWWgGicLYc22EN3nixExB_j9FSVE6jefPmzei9A7Q3xMEh9A3DEcYc_1gsLxfXq_nV8vxsfjovWHsEtMWcfUAzzEhTN4zKPTQDAFkLSsg-Osj5trScCvYJ7VNgknBOZujX3ymP2g-688GPT1Xsq-MQo60ukst5Sq66dHYyo49D5Ycy0-auOtapcymv4zZ_Rh97HbL78loP0fWf31eL03p1frJczFe1aXjb1I7rviOMUIIlhl5QTUrHBHa9azpNrOgsoZYzqw23kptWtBp6y5ikvegMPUQ_d7rbqds4a9wwJh3UNvmNTk8qaq_eTwa_VjfxQXGJRdPiIvD9VSDF-8nlUW18Ni4EPbg4ZUWKsQIIAShUuaOaFHNOrn87g0G9BKDeB1CwVu0CKLtf___zbfOf44XQ7AiPMYzFxLswPbqk1k6Hca1KREABi5oAloCBQP0CNfQZV0CViQ
CitedBy_id crossref_primary_10_1093_ajh_hpab187
crossref_primary_10_1161_HYPERTENSIONAHA_121_17570
crossref_primary_10_1177_00111287221130956
crossref_primary_10_1055_s_0043_1778639
crossref_primary_10_1161_HYPERTENSIONAHA_119_13542
crossref_primary_10_1016_j_jacc_2022_06_028
crossref_primary_10_1161_HYPERTENSIONAHA_123_21100
crossref_primary_10_1097_HCO_0000000000000674
crossref_primary_10_1016_j_lanwpc_2023_100839
crossref_primary_10_1161_JAHA_123_032370
crossref_primary_10_1161_JAHA_120_020796
crossref_primary_10_1007_s40620_022_01516_5
crossref_primary_10_5888_pcd17_200277
crossref_primary_10_1161_JAHA_121_020997
crossref_primary_10_1007_s11886_022_01826_x
crossref_primary_10_3390_pharmacy11030093
crossref_primary_10_1161_CIRCULATIONAHA_120_051782
crossref_primary_10_1001_jamapediatrics_2021_1112
crossref_primary_10_1371_journal_pone_0261030
crossref_primary_10_1007_s40615_022_01474_5
crossref_primary_10_1161_JAHA_122_025271
crossref_primary_10_1056_NEJMp1912293
crossref_primary_10_1093_ajh_hpab053
crossref_primary_10_1007_s11606_020_05764_8
crossref_primary_10_1097_HCO_0000000000000742
crossref_primary_10_1007_s11886_020_01319_9
crossref_primary_10_1161_CIR_0000000000001096
crossref_primary_10_1016_j_ajpc_2021_100250
crossref_primary_10_4102_safp_v64i1_5434
crossref_primary_10_1016_j_jacc_2019_08_1001
crossref_primary_10_1080_28338073_2023_2269074
crossref_primary_10_1097_HJH_0000000000003480
crossref_primary_10_2337_cd23_0063
crossref_primary_10_1161_CIRCULATIONAHA_118_038240
crossref_primary_10_1007_s11606_020_06012_9
crossref_primary_10_1016_j_cjca_2024_01_028
crossref_primary_10_1038_s41582_023_00921_z
crossref_primary_10_1001_jamacardio_2024_1463
crossref_primary_10_1093_ajh_hpab162
crossref_primary_10_1161_STROKEAHA_120_030427
crossref_primary_10_1093_eurheartj_ehae142
crossref_primary_10_1161_CIR_0000000000001141
crossref_primary_10_1186_s12889_023_16210_9
crossref_primary_10_1177_15579883231152114
crossref_primary_10_18553_jmcp_2022_28_3_379
crossref_primary_10_1161_CIRCOUTCOMES_123_009867
crossref_primary_10_1161_HYPERTENSIONAHA_122_20292
crossref_primary_10_1161_CIRCULATIONAHA_120_051683
crossref_primary_10_1161_CIRCHEARTFAILURE_119_006445
crossref_primary_10_1038_s41581_020_00363_6
crossref_primary_10_1093_ehjdh_ztab003
crossref_primary_10_1161_CIRCULATIONAHA_120_050670
crossref_primary_10_1371_journal_pone_0303075
crossref_primary_10_1016_j_pcad_2019_12_002
crossref_primary_10_1093_ajh_hpz021
crossref_primary_10_1177_15443167221076128
crossref_primary_10_1097_MLR_0000000000001813
crossref_primary_10_1038_s41371_020_0331_7
crossref_primary_10_1155_2019_2470801
crossref_primary_10_1161_CIRCOUTCOMES_120_006780
crossref_primary_10_1186_s12889_021_11584_0
crossref_primary_10_1016_S0140_6736_21_02252_2
crossref_primary_10_1002_ccd_29751
crossref_primary_10_1007_s11906_019_0996_x
crossref_primary_10_1161_JAHA_122_026347
crossref_primary_10_1161_JAHA_121_024785
crossref_primary_10_1093_ajh_hpad009
Cites_doi 10.1002/9780470977811
10.1161/CIRCULATIONAHA.115.015464
10.1331/JAPhA.2013.12246
10.1191/1740774504cn006rr
10.1161/CIRCOUTCOMES.109.850008
10.1161/JAHA.116.004432
10.1111/bcp.12452
10.1201/9781584888178
10.1007/s10900-013-9744-3
10.1001/archinte.168.12.1285
10.1056/NEJMoa1511939
10.5811/westjem.2017.1.30532
10.1056/NEJMe1803106
10.1161/CIRCOUTCOMES.112.968172
10.1161/HYPERTENSIONAHA.116.08043
10.1161/HYPERTENSIONAHA.114.05021
10.1001/archinternmed.2010.390
10.1016/j.ijsu.2011.09.004
10.1016/j.jacc.2017.11.006
10.1186/s12874-017-0368-7
10.1097/01.NNR.0000289501.45284.6e
10.1056/NEJMc1806026
10.1097/01.hjh.0000431740.32696.cc
10.1002/phar.1732
10.1056/NEJMoa1717250
10.1097/01.mlr.0000160375.47920.8c
10.1161/HYPERTENSIONAHA.115.05138
10.1056/NEJMsa1107913
10.1161/JAHA.113.000718
10.1001/jama.299.24.2857
10.1161/HYPERTENSIONAHA.106.080432
10.5888/pcd14.160423
10.1001/jama.2013.6549
ContentType Journal Article
Copyright 2019 by the American College of Cardiology Foundation and the American Heart Association, Inc.
Copyright_xml – notice: 2019 by the American College of Cardiology Foundation and the American Heart Association, Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1161/CIRCULATIONAHA.118.038165
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1524-4539
EndPage 19
ExternalDocumentID 10_1161_CIRCULATIONAHA_118_038165
30592662
00003017-201901020-00004
Genre Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations Los Angeles
GeographicLocations_xml – name: Los Angeles
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: R01 HL117983
– fundername: NCATS NIH HHS
  grantid: UL1 TR001881
GroupedDBID -
.XZ
.Z2
01R
0R
1AW
1J1
29B
2WC
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O
7O~
8RP
AAAXR
AAMOA
AAMTA
AAPBV
AARTV
AAWTL
AAXQO
ABBUW
ABFLS
ABOCM
ABPMR
ABPTK
ABUFD
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFS
ACRKK
ACWDW
ACWRI
ACXNZ
ADBBV
ADCYY
AENEX
AFCHL
AFUWQ
AHMBA
AHULI
AHVBC
AIJEX
AJIOK
ALMA_UNASSIGNED_HOLDINGS
AMJPA
ASCII
ASPBG
AVWKF
AWKKM
AZFZN
BAWUL
BOYCO
BQLVK
BYPQX
C45
CS3
DIK
DU5
E3Z
EBS
EJD
EX3
F2K
F2L
F2M
F2N
F5P
GX1
H0
H0~
H1
HZ
IKYAY
IN
IN~
JF9
JG8
JK3
K8S
KD2
KMI
KQ8
L-C
L7B
N9A
N~7
N~B
O0-
O9-
OAG
OAH
OBH
OCB
ODA
OGEVE
OHASI
OK1
OL1
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWW
OWY
OXXIT
P2P
PQEST
PQQKQ
RAH
RHF
RIG
RLZ
RSW
S4R
S4S
UPT
V2I
W2D
WH7
WOQ
WOW
X3V
X3W
XZ
YZZ
Z2
ZA5
ZY1
~H1
---
.-D
.3C
0R~
0ZK
18M
2FS
354
6PF
AAAAV
AAGIX
AAHPQ
AAIQE
AAJCS
AAQKA
AASCR
AASOK
AASXQ
AAUEB
ABASU
ABDIG
ABJNI
ABQRW
ABVCZ
ACGFO
ACILI
ACLDA
ACOAL
ACXJB
ADGGA
ADHPY
AE3
AE6
AEBDS
AFDTB
AFEXH
AFSOK
AGINI
AHOMT
AHQNM
AHRYX
AINUH
AJNWD
AJZMW
AKULP
ALMTX
AMKUR
AMNEI
AOHHW
AYCSE
CGR
CUY
CVF
DIWNM
ECM
EEVPB
EIF
ERAAH
FCALG
GNXGY
GQDEL
HLJTE
HZ~
IKREB
IPNFZ
K-A
K-F
NPM
ODMTH
OHH
OHYEH
OJAPA
OLB
OWBYB
OWU
OWV
OWX
OWZ
T8P
TEORI
TR2
TSPGW
VVN
W3M
W8F
XXN
XYM
YFH
YOC
YSK
YYM
ZFV
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c4684-e6afb252321910f73a2252571efe4ba2d7bd23d65dac6d96c878a0fd5593f7bc3
ISSN 0009-7322
1524-4539
IngestDate Tue Sep 17 20:58:51 EDT 2024
Sat Oct 26 04:37:04 EDT 2024
Fri Dec 06 04:40:20 EST 2024
Sat Nov 02 12:23:59 EDT 2024
Thu Aug 13 19:52:50 EDT 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords hypertension
ethnic groups
continental population groups
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4684-e6afb252321910f73a2252571efe4ba2d7bd23d65dac6d96c878a0fd5593f7bc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
We wish to dedicate this paper to Ronald G. Victor, MD, the study’s architect and our beloved colleague, mentor and friend who passed away shortly before publication.
OpenAccessLink https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.118.038165
PMID 30592662
PQID 2161702200
PQPubID 23479
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6917481
proquest_miscellaneous_2161702200
crossref_primary_10_1161_CIRCULATIONAHA_118_038165
pubmed_primary_30592662
wolterskluwer_health_00003017-201901020-00004
ProviderPackageCode OVOZU
L-C
C45
7O~
AARTV
ABPMR
OLH
ASCII
BYPQX
OLG
AAMOA
ODA
ABZAD
ABBUW
JK3
H0~
1J1
OLV
OLU
JG8
OLW
OLZ
OLY
F2K
F2M
F2L
F2N
OHASI
AHVBC
KMI
OGEVE
K8S
OVLEI
AJIOK
OPUJH
V2I
.XZ
S4R
S4S
4Q1
OAG
4Q2
OVDNE
4Q3
AMJPA
OAH
OVD
71W
AHULI
ACEWG
.Z2
N~7
IKYAY
OVIDH
AWKKM
40H
N~B
OBH
X3V
X3W
ACDDN
ACWRI
BOYCO
AIJEX
AAXQO
~H1
AAMTA
AAAXR
OWW
OCB
OWY
01R
ACXNZ
OL1
AFCHL
ABXVJ
IN~
KD2
OXXIT
77Y
ACWDW
JF9
PublicationCentury 2000
PublicationDate 2019-January-2
2019-01-02
20190102
PublicationDateYYYYMMDD 2019-01-02
PublicationDate_xml – month: 01
  year: 2019
  text: 2019-January-2
  day: 02
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Circulation (New York, N.Y.)
PublicationTitleAlternate Circulation
PublicationYear 2019
Publisher by the American College of Cardiology Foundation and the American Heart Association, Inc
Publisher_xml – name: by the American College of Cardiology Foundation and the American Heart Association, Inc
References 30592660 - Circulation. 2019 Jan 2;139(1):20-23. doi: 10.1161/CIRCULATIONAHA.118.038240
e_1_3_4_3_2
e_1_3_4_2_2
Elashoff RM (e_1_3_4_24_2) 2017
e_1_3_4_9_2
e_1_3_4_8_2
e_1_3_4_7_2
e_1_3_4_6_2
e_1_3_4_5_2
e_1_3_4_4_2
e_1_3_4_22_2
e_1_3_4_23_2
e_1_3_4_20_2
e_1_3_4_21_2
e_1_3_4_26_2
e_1_3_4_27_2
e_1_3_4_25_2
e_1_3_4_28_2
e_1_3_4_29_2
Anwar YA (e_1_3_4_16_2) 1997; 2
e_1_3_4_30_2
e_1_3_4_11_2
e_1_3_4_34_2
e_1_3_4_12_2
e_1_3_4_33_2
e_1_3_4_32_2
e_1_3_4_10_2
e_1_3_4_31_2
e_1_3_4_15_2
e_1_3_4_13_2
e_1_3_4_36_2
e_1_3_4_14_2
e_1_3_4_35_2
e_1_3_4_19_2
e_1_3_4_17_2
e_1_3_4_18_2
References_xml – ident: e_1_3_4_23_2
  doi: 10.1002/9780470977811
– ident: e_1_3_4_5_2
  doi: 10.1161/CIRCULATIONAHA.115.015464
– ident: e_1_3_4_7_2
  doi: 10.1331/JAPhA.2013.12246
– ident: e_1_3_4_12_2
  doi: 10.1191/1740774504cn006rr
– ident: e_1_3_4_26_2
  doi: 10.1161/CIRCOUTCOMES.109.850008
– ident: e_1_3_4_10_2
  doi: 10.1161/JAHA.116.004432
– ident: e_1_3_4_3_2
  doi: 10.1111/bcp.12452
– ident: e_1_3_4_22_2
  doi: 10.1201/9781584888178
– ident: e_1_3_4_8_2
  doi: 10.1007/s10900-013-9744-3
– ident: e_1_3_4_20_2
  doi: 10.1001/archinte.168.12.1285
– ident: e_1_3_4_30_2
  doi: 10.1056/NEJMoa1511939
– ident: e_1_3_4_13_2
  doi: 10.5811/westjem.2017.1.30532
– ident: e_1_3_4_36_2
  doi: 10.1056/NEJMe1803106
– ident: e_1_3_4_32_2
  doi: 10.1161/CIRCOUTCOMES.112.968172
– ident: e_1_3_4_6_2
  doi: 10.1161/HYPERTENSIONAHA.116.08043
– ident: e_1_3_4_14_2
  doi: 10.1161/HYPERTENSIONAHA.114.05021
– ident: e_1_3_4_17_2
  doi: 10.1001/archinternmed.2010.390
– ident: e_1_3_4_11_2
  doi: 10.1016/j.ijsu.2011.09.004
– volume-title: Joint Modeling of Longitudinal and Time-to-Event Data
  year: 2017
  ident: e_1_3_4_24_2
  contributor:
    fullname: Elashoff RM
– ident: e_1_3_4_25_2
  doi: 10.1016/j.jacc.2017.11.006
– ident: e_1_3_4_28_2
  doi: 10.1186/s12874-017-0368-7
– ident: e_1_3_4_34_2
  doi: 10.1097/01.NNR.0000289501.45284.6e
– volume: 2
  start-page: 105
  year: 1997
  ident: e_1_3_4_16_2
  article-title: Evaluation of the Datascope Accutorr Plus according to the recommendations of the Association for the Advancement of Medical Instrumentation.
  publication-title: Blood Press Monit
  contributor:
    fullname: Anwar YA
– ident: e_1_3_4_27_2
  doi: 10.1056/NEJMc1806026
– ident: e_1_3_4_19_2
  doi: 10.1097/01.hjh.0000431740.32696.cc
– ident: e_1_3_4_4_2
  doi: 10.1002/phar.1732
– ident: e_1_3_4_9_2
  doi: 10.1056/NEJMoa1717250
– ident: e_1_3_4_21_2
  doi: 10.1097/01.mlr.0000160375.47920.8c
– ident: e_1_3_4_15_2
  doi: 10.1161/HYPERTENSIONAHA.115.05138
– ident: e_1_3_4_29_2
  doi: 10.1056/NEJMsa1107913
– ident: e_1_3_4_2_2
  doi: 10.1161/JAHA.113.000718
– ident: e_1_3_4_31_2
  doi: 10.1001/jama.299.24.2857
– ident: e_1_3_4_18_2
  doi: 10.1161/HYPERTENSIONAHA.106.080432
– ident: e_1_3_4_35_2
  doi: 10.5888/pcd14.160423
– ident: e_1_3_4_33_2
  doi: 10.1001/jama.2013.6549
SSID ssj0006375
Score 2.59357
Snippet BACKGROUND:We developed a new model of hypertension care for non-Hispanic black men that links health promotion by barbers to medication management by American...
We developed a new model of hypertension care for non-Hispanic black men that links health promotion by barbers to medication management by American Society of...
SourceID pubmedcentral
proquest
crossref
pubmed
wolterskluwer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 10
SubjectTerms Adult
Aged
Antihypertensive Agents - therapeutic use
Barbering
Black or African American - psychology
Blood Pressure - drug effects
Community Pharmacy Services - organization & administration
Cultural Characteristics
Health Knowledge, Attitudes, Practice - ethnology
Health Promotion - organization & administration
Humans
Hypertension - drug therapy
Hypertension - ethnology
Hypertension - physiopathology
Hypertension - psychology
Los Angeles
Male
Middle Aged
Patient Acceptance of Health Care - ethnology
Pharmacists - organization & administration
Professional Role
Time Factors
Treatment Outcome
Title Sustainability of Blood Pressure Reduction in Black Barbershops
URI http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00003017-201901020-00004
https://www.ncbi.nlm.nih.gov/pubmed/30592662
https://www.proquest.com/docview/2161702200
https://pubmed.ncbi.nlm.nih.gov/PMC6917481
Volume 139
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9NAEF_KCeVARO_8qKeSA_EtNdlsNuljLWqVq4hepW8h2exywbuktD2Oin-8M7ubNKEn6L2EdtPm6zeZnZmd3wwhryMqVcwDAZZbnLoskNKNqS9ckSpPyiwTmaaLzb7w6Zx9XoSLXu93m12yyYbi1628krugCmOAK7Jk_wPZ5qAwAJ8BX9gCwrD9J4y_1-yn4tJmVrzDPHTL-VthS4bcVIfFsIaO1ekFBsxdrpbrtmE6KVbCdvK6rUFPK2DwozBxfszKLnU8a9j49JfbmlhYIGKAfrPvrDCCZ2dKHNmWpg9VndHRjkAg6cl3PdrRqiM3Cgy_eCitIqXMZaEpVNRoWvu1LVJGb9rUVjMDGx26r9s56vbJp2-T-ZmpFDwdw2g81IufYfs_ANPySoMO6mwENgjdTXf1Ev_X2YSDr8qQt38Pyyhi54WPi12CEA-isO7Dh3fXJ6f2Mt7-9SIOSb8-Y9fQ2fNe9pNw799UmCCx_qn5ES0r5_wheWDdE2dsZO0R6cnyiByPy3RTXW2dN45OGNYrMUekP7N5Gcfg8nUk0amUoyXRqSXRaSTRKUpHS6LTksTHZP7h_flk6trWHK5gPGau5KnKaAjmOPj7noqCFOYF0P6-VJJlKc2jLKdBzsM8FTwfcRGDKvBUDv5roKJMBE_IQVmV8hlxQgUWtcoUCAtj0vMzquKYC8GY4rEf0AGh9XNMlqYCS6I9V-4nXRxgLE4MDgNyWj_xBPQlLoKlpayu1wlFhx7p5d6APDUINIetoRuQqINN8wOsxd7dUxYXuia7FaUBcTsoJobNjCkeGHuIXHx_sIyjLufgsed3PtMJOdy9iy_IwWZ1LV-CfbzJXmkx_gMdzrTA
link.rule.ids 230,314,780,784,885,27924,27925
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sustainability+of+Blood+Pressure+Reduction+in+Black+Barbershops&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Victor%2C+Ronald+G.&rft.au=Blyler%2C+Ciantel+A.&rft.au=Li%2C+Ning&rft.au=Lynch%2C+Kathleen&rft.date=2019-01-02&rft.issn=0009-7322&rft.eissn=1524-4539&rft.volume=139&rft.issue=1&rft.spage=10&rft.epage=19&rft_id=info:doi/10.1161%2FCIRCULATIONAHA.118.038165&rft_id=info%3Apmid%2F30592662&rft.externalDBID=PMC6917481
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon